Clinical Trial

Mesenteric Vascular Preconditioning Combined With Laparoscopic and Endoscopic Cooperative Surgery for Submucosal Tumor at the Gastroesophageal Junction

Study acronym: SAVE-GEJ
Enrolling by Invitation Phase 2
View on ClinicalTrials.gov →
Summary
This study is a single-center, prospective, single-arm, exploratory clinical study (phase II exploratory trial). No parallel control group was established in the study, and all subjects who met the inclusion criteria underwent a uniform surgical treatment approach, namely, double-scope combined resection with mesenteric vascular preconditioning. The study aims to preliminarily evaluate the safety and effectiveness of this novel surgical strategy for the treatment of submucosal tumor at the gastroesophageal junction, and to provide data support for subsequent larger-scale controlled studies.
Protocol Amendment History 1 change
minor Completion pushed: 2028-03-30 -> 2031-03-30 2026-05-01
Trial Details
NCT Number NCT07550582
Lead Sponsor Peking University People's Hospital
Conditions Submucosal Tumor of Gastrointestinal Tract, Gastrointestinal Stromal Tumor (GIST)
Enrollment 40 participants
Start Date 2026-04-01
Primary Completion 2028-03-30 (estimated)
Study Completion 2031-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-30